The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early detection of competing resistance mutations using plasma next-generation sequencing (NGS) in patients (pts) with EGFR-mutant NSCLC treated with osimertinib.
 
Nicolas Marie Guibert
No Relationships to Disclose
 
Cloud Paweletz
Honoraria - Bio-Rad
 
Yuebi Hu
No Relationships to Disclose
 
Nora B. Feeney
No Relationships to Disclose
 
Vincent Plagnol
Employment - Inivata
Leadership - Inivata
Stock and Other Ownership Interests - Inivata
 
Valerie Poole
Employment - Inivata
Stock and Other Ownership Interests - Inivata
Research Funding - Inivata
 
Greg Jones
Employment - Inc Research; Inivata; MDxHealth
Stock and Other Ownership Interests - MDxHealth
Consulting or Advisory Role - MDxHealth
 
Geoffrey R. Oxnard
Honoraria - AstraZeneca; Chugai Pharma
Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Genentech/Roche; Inivata; Sysmex; Takeda
Patents, Royalties, Other Intellectual Property - DFCI has a patent pending titled "Non-invasive blood-based monitoring of genomic alterations in cancer", on which I am a co-author. (Inst)